12th Dec 2022 12:00
Poolbeg Pharma PLC Poolbeg Pharma receives initial results from human challenge clinical study 12.12.2022 / 12:59 CET/CEST The issuer is solely responsible for the content of this announcement. 12.12.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com |
| Language: | English |
| Company: | Poolbeg Pharma PLC |
| United States | |
| ISIN: | GB00BKPG7Z60 |
| EQS News ID: | 1510681 |
| End of News | EQS News Service |
1510681 12.12.2022 CET/CEST
corporate announcement transmitted by EQS Group AG. The issuer is solely responsible for the content of this announcement.
Related Shares:
Poolbeg Pharma